Medicago's P2P Acquisition

Medicago raised a round of funding on September 18, 2013. Investors include Mitsubishi Tanabe Pharma.

Medicago is committed to provide highly effective and affordable vaccines based on proprietary Virus-Like Particle (VLP) and manufacturing technologies. Medicago is developing VLP vaccines to protect …

Articles about Medicago's P2P Acquisition: